Galectins in Cancer and Translational Medicine / / Armando Bartolazzi.
In the post-genomic era, many efforts have been devoted to better understanding the biological information encoded by the cell "glycome" in normal and pathologic conditions. The glycan signature of human cells plays a pivotal role in regulating fundamental biological processes, which are c...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | Basel, Switzerland : : MDPI - Multidisciplinary Digital Publishing Institute,, 2018. |
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 online resource (350 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993602969004498 |
---|---|
ctrlnum |
(CKB)4920000000101661 (NjHacI)994920000000101661 (EXLCZ)994920000000101661 |
collection |
bib_alma |
record_format |
marc |
spelling |
Bartolazzi, Armando, author. Galectins in Cancer and Translational Medicine / Armando Bartolazzi. Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute, 2018. 1 online resource (350 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. In the post-genomic era, many efforts have been devoted to better understanding the biological information encoded by the cell "glycome" in normal and pathologic conditions. The glycan signature of human cells plays a pivotal role in regulating fundamental biological processes, which are critical for cell physiology and for cancer as well. Galectins (also worded S-type lectins) are an evolutionarily conserved family of endogenous lectins, which bind carbohydrates with high specificity. These molecules, which can be found both intracellularly and in the extracellular milieu, are functionally active in converting glycan-containing information into cell biological programs. This fashionable mechanism of signal transduction plays a relevant role in regulating several biological functions, including RNA splicing, gene transcription, cell migration and differentiation, apoptosis, immune response, and tumor growth and progression. It is not surprising, indeed, that a large number of studies on galectin-glycan interactions and galectins expression and function in human diseases have been published in the recent literature, spanning from immunology to cardiovascular medicine, from diagnostic Pathology to nuclear medicine. The aim of this Special Issue of IJMS is to collect selected contributions in the field reporting data, concepts, and new ideas, which have the potential to be translated in a clinical setting in the near future, in order to improve the diagnosis and treatment of cancer and other relevant human diseases. Protein binding. Cancer. 3-03897-408-0 |
language |
English |
format |
eBook |
author |
Bartolazzi, Armando, |
spellingShingle |
Bartolazzi, Armando, Galectins in Cancer and Translational Medicine / |
author_facet |
Bartolazzi, Armando, |
author_variant |
a b ab |
author_role |
VerfasserIn |
author_sort |
Bartolazzi, Armando, |
title |
Galectins in Cancer and Translational Medicine / |
title_full |
Galectins in Cancer and Translational Medicine / Armando Bartolazzi. |
title_fullStr |
Galectins in Cancer and Translational Medicine / Armando Bartolazzi. |
title_full_unstemmed |
Galectins in Cancer and Translational Medicine / Armando Bartolazzi. |
title_auth |
Galectins in Cancer and Translational Medicine / |
title_new |
Galectins in Cancer and Translational Medicine / |
title_sort |
galectins in cancer and translational medicine / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2018 |
physical |
1 online resource (350 pages) |
isbn |
3-03897-408-0 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC261 |
callnumber-sort |
RC 3261 B378 42018 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.994 |
dewey-sort |
3616.994 |
dewey-raw |
616.994 |
dewey-search |
616.994 |
work_keys_str_mv |
AT bartolazziarmando galectinsincancerandtranslationalmedicine |
status_str |
n |
ids_txt_mv |
(CKB)4920000000101661 (NjHacI)994920000000101661 (EXLCZ)994920000000101661 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Galectins in Cancer and Translational Medicine / |
_version_ |
1796653186457534465 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02485nam a2200289 i 4500</leader><controlfield tag="001">993602969004498</controlfield><controlfield tag="005">20230629113801.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230629s2018 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000101661</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000000101661</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000101661</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC261</subfield><subfield code="b">.B378 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bartolazzi, Armando,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Galectins in Cancer and Translational Medicine /</subfield><subfield code="c">Armando Bartolazzi.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (350 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In the post-genomic era, many efforts have been devoted to better understanding the biological information encoded by the cell "glycome" in normal and pathologic conditions. The glycan signature of human cells plays a pivotal role in regulating fundamental biological processes, which are critical for cell physiology and for cancer as well. Galectins (also worded S-type lectins) are an evolutionarily conserved family of endogenous lectins, which bind carbohydrates with high specificity. These molecules, which can be found both intracellularly and in the extracellular milieu, are functionally active in converting glycan-containing information into cell biological programs. This fashionable mechanism of signal transduction plays a relevant role in regulating several biological functions, including RNA splicing, gene transcription, cell migration and differentiation, apoptosis, immune response, and tumor growth and progression. It is not surprising, indeed, that a large number of studies on galectin-glycan interactions and galectins expression and function in human diseases have been published in the recent literature, spanning from immunology to cardiovascular medicine, from diagnostic Pathology to nuclear medicine. The aim of this Special Issue of IJMS is to collect selected contributions in the field reporting data, concepts, and new ideas, which have the potential to be translated in a clinical setting in the near future, in order to improve the diagnosis and treatment of cancer and other relevant human diseases.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Protein binding.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03897-408-0</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:04:17 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338060220004498&Force_direct=true</subfield><subfield code="Z">5338060220004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338060220004498</subfield></datafield></record></collection> |